{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:35:17Z","timestamp":1792816517202,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12602-025-10716-x","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T09:46:15Z","timestamp":1755251175000},"page":"3303-3317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of Probiotics and Synbiotics Supplementation on Blood Pressure in Adults with Prediabetes and Type 2 Diabetes Mellitus: A Grade-Assessed Systematic Review and Dose\u2013Response Meta-Analysis"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4305-9992","authenticated-orcid":false,"given":"Azin","family":"Setayesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4388-0214","authenticated-orcid":false,"given":"Mehdi","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-4711","authenticated-orcid":false,"given":"Omid","family":"Asbaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5011-0742","authenticated-orcid":false,"given":"Amin","family":"Mohammad Niaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3684-3988","authenticated-orcid":false,"given":"Hoda","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6404-8367","authenticated-orcid":false,"given":"Seyed Hossein","family":"Davoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-7597","authenticated-orcid":false,"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"issue":"4","key":"10716_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/14737167.2020.1782748","volume":"21","author":"A Alzaid","year":"2021","unstructured":"Alzaid A, Ladr\u00f3n de Guevara P, Beillat M, Lehner Martin V, Atanasov P (2021) Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses. Exp Rev Pharmacoeconomics Outcomes Res 21(4):785\u2013798","journal-title":"Exp Rev Pharmacoeconomics Outcomes Res"},{"key":"10716_CR2","doi-asserted-by":"publisher","unstructured":"Aschner P, Karuranga S, James S, Simmons D, Basit A, Shaw JE, Wild SH, Ogurtsova K, Saeedi P (2021) International Diabetes Federation's Diabetes Epidemiological Guide Writing Group. The International Diabetes Federation's guide for diabetes epidemiological studies. Diabetes Res Clin Pract 172:108630. https:\/\/doi.org\/10.1016\/j.diabres.2020.108630","DOI":"10.1016\/j.diabres.2020.108630"},{"issue":"8","key":"10716_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S2213-8587(21)00113-3","volume":"9","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Wefers J, Meier JJ (2021) Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol 9(8):525\u2013544","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10716_CR4","unstructured":"World Health O, International Diabetes F (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia\u202f: report of a WHO\/IDF consultation. World Health Organization, Geneva"},{"key":"10716_CR5","doi-asserted-by":"publisher","unstructured":"American Diabetes Association (2014)Diagnosis and classification of diabetes mellitus. Diabetes Care. Suppl 1:S81-90. https:\/\/doi.org\/10.2337\/dc14-S081","DOI":"10.2337\/dc14-S081"},{"issue":"4","key":"10716_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.55544\/jrasb.3.4.15","volume":"3","author":"SR Haidari","year":"2024","unstructured":"Haidari SR, Haidary SQA (2024) Prevalence and risk factors of hypertension among diabetic patients. J Res Appl Sci Biotechnol 3(4):126\u2013131","journal-title":"J Res Appl Sci Biotechnol"},{"issue":"8","key":"10716_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.5543\/tkda.2014.53384","volume":"42","author":"N Kahya Eren","year":"2014","unstructured":"Kahya Eren N, Harman E, Dolek D, T\u00fct\u00fcnc\u00fco\u011flu AP, Emren SV, Levent F et al (2014) Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Turk Kardiyol Dern Ars 42(8):733\u2013740","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"1","key":"10716_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13098-025-01833-2","volume":"17","author":"M Karimi","year":"2025","unstructured":"Karimi M, Karimi MA, Fayedeh F, Ziyafati Kafi F, Kazemi K, Jahangiri S et al (2025) Effects of vitamin E administration on serum lipid profile in diabetic patients: a grade-assessed systematic review and dose-response meta-analysis of RCTs. Diabetol Metab Syndr 17(1):280","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"10716_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s40200-025-01682-w","volume":"24","author":"M Karimi","year":"2025","unstructured":"Karimi M, Bahreini N, Pirzad S, Pourfaraji SMA, Shirsalimi N, Asbaghi O et al (2025) Propolis supplementation improves cardiometabolic health in patients with type 2 diabetes mellitus: findings from a GRADE-assessed systematic review and meta-analysis of RCTs. J Diabetes Metab Disord 24(2):164","journal-title":"J Diabetes Metab Disord"},{"key":"10716_CR10","first-page":"200424","volume":"26","author":"M Karimi","year":"2025","unstructured":"Karimi M, Pirzad S, Hooshmand F, Shirsalimi N, Pourfaraji SMA (2025) Effects of coenzyme Q10 administration on blood pressure and heart rate in adults: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol Cardiovasc Risk Prev 26:200424","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"10716_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00029","author":"C G\u00e9rard","year":"2019","unstructured":"G\u00e9rard C, Vidal H (2019) Impact of gut microbiota on host glycemic control. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00029","journal-title":"Front Endocrinol"},{"key":"10716_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040452","author":"N Naderpoor","year":"2019","unstructured":"Naderpoor N, Mousa A, Gomez-Arango LF, Barrett HL, Dekker Nitert M, de Courten B (2019) Faecal microbiota are related to insulin sensitivity and secretion in overweight or obese adults. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8040452","journal-title":"J Clin Med"},{"issue":"1","key":"10716_CR13","first-page":"986734","volume":"2013","author":"BM Carvalho","year":"2013","unstructured":"Carvalho BM, Abdalla Saad MJ (2013) Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm 2013(1):986734","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10716_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/nu5030829","volume":"5","author":"AM Caricilli","year":"2013","unstructured":"Caricilli AM, Saad MJA (2013) The role of gut microbiota on insulin resistance. Nutrients 5(3):829\u2013851","journal-title":"Nutrients"},{"key":"10716_CR15","doi-asserted-by":"publisher","first-page":"goab046","DOI":"10.1093\/gastro\/goab046","volume":"10","author":"M Yadav","year":"2022","unstructured":"Yadav M, Chauhan NS (2022) Microbiome therapeutics: exploring the present scenario and challenges. Gastroenterol Rep 10:goab046","journal-title":"Gastroenterol Rep"},{"key":"10716_CR16","doi-asserted-by":"publisher","first-page":"1439176","DOI":"10.3389\/fimmu.2024.1439176","volume":"15","author":"M Karimi","year":"2024","unstructured":"Karimi M, Shirsalimi N, Hashempour Z, Salehi Omran H, Sedighi E, Beigi F et al (2024) Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front Immunol 15:1439176","journal-title":"Front Immunol"},{"issue":"11","key":"10716_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K et al (2020) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 17(11):687\u2013701","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10716_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/1751-7915.12789","volume":"10","author":"T Gurry","year":"2017","unstructured":"Gurry T (2017) Synbiotic approaches to human health and well-being. Microb Biotechnol 10(5):1070\u20131073","journal-title":"Microb Biotechnol"},{"key":"10716_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.earlhumdev.2019.05.010","volume":"135","author":"K Halloran","year":"2019","unstructured":"Halloran K, Underwood MA (2019) Probiotic mechanisms of action. Early Hum Dev 135:58\u201365","journal-title":"Early Hum Dev"},{"issue":"1","key":"10716_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S095442241700018X","volume":"31","author":"YA Kim","year":"2018","unstructured":"Kim YA, Keogh JB, Clifton PM (2018) Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr Res Rev 31(1):35\u201351","journal-title":"Nutr Res Rev"},{"issue":"11","key":"10716_CR21","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2337\/db11-0227","volume":"60","author":"A Everard","year":"2011","unstructured":"Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM et al (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60(11):2775\u20132786","journal-title":"Diabetes"},{"issue":"2","key":"10716_CR22","first-page":"543","volume":"62","author":"K Naseri","year":"2023","unstructured":"Naseri K, Saadati S, Ghaemi F, Ashtary-Larky D, Asbaghi O, Sadeghi A et al (2023) The effects of probiotic and synbiotic supplementation on inflammation, oxidative stress, and circulating adiponectin and leptin concentration in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Eur J Nutr 62(2):543\u2013561","journal-title":"Eur J Nutr"},{"key":"10716_CR23","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj 372","DOI":"10.1136\/bmj.n71"},{"key":"10716_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2020-209567","author":"M Amir-Behghadami","year":"2020","unstructured":"Amir-Behghadami M, Janati A (2020) Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. https:\/\/doi.org\/10.1136\/emermed-2020-209567","journal-title":"Emerg Med J"},{"key":"10716_CR25","doi-asserted-by":"publisher","unstructured":"Higgins JP et al. (2019) Assessing risk of bias in a randomized trial, in Cochrane Handbook for Systematic Reviews of Interventions. pp 205\u2013228. https:\/\/doi.org\/10.1002\/9781119536604.ch8","DOI":"10.1002\/9781119536604.ch8"},{"issue":"1","key":"10716_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/ds.DS-D-22-00154","volume":"41","author":"S-C Shao","year":"2023","unstructured":"Shao S-C, Kuo L-T, Huang Y-T, Lai P-C, Chi C-C (2023) Using grading of recommendations assessment, development, and evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial. Dermatol Sin 41(1):3\u20137","journal-title":"Dermatol Sin"},{"issue":"3","key":"10716_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"key":"10716_CR28","doi-asserted-by":"publisher","first-page":"155050","DOI":"10.1016\/j.cyto.2020.155050","volume":"129","author":"O Asbaghi","year":"2020","unstructured":"Asbaghi O, Sadeghian M, Mozaffari-Khosravi H, Maleki V, Shokri A, Hajizadeh-Sharafabad F et al (2020) The effect of vitamin D-calcium co-supplementation on inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials. Cytokine 129:155050","journal-title":"Cytokine"},{"key":"10716_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"10716_CR30","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jclinepi.2010.08.010","volume":"64","author":"R Fu","year":"2011","unstructured":"Fu R, Gartlehner G, Grant M, Shamliyan T, Sedrakyan A, Wilt TJ et al (2011) Conducting quantitative synthesis when comparing medical interventions: AHRQ and the effective health care program. J Clin Epidemiol 64(11):1187\u20131197","journal-title":"J Clin Epidemiol"},{"key":"10716_CR31","unstructured":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet] (2008) Rockville (MD): Agency for Healthcare Research and Quality (US). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK47095\/"},{"key":"10716_CR32","doi-asserted-by":"publisher","DOI":"10.2307\/2533446","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics. https:\/\/doi.org\/10.2307\/2533446","journal-title":"Biometrics"},{"issue":"7109","key":"10716_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"3","key":"10716_CR34","first-page":"138","volume":"16","author":"C Xu","year":"2018","unstructured":"Xu C, Doi SA (2018) The robust error meta-regression method for dose\u2013response meta-analysis. JBI Evid Implement 16(3):138\u2013144","journal-title":"JBI Evid Implement"},{"issue":"4","key":"10716_CR35","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.clnu.2020.10.032","volume":"40","author":"Y Xie","year":"2021","unstructured":"Xie Y, Gou L, Peng M, Zheng J, Chen L (2021) Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 40(4):1800\u20131810","journal-title":"Clin Nutr"},{"key":"10716_CR36","doi-asserted-by":"publisher","unstructured":"Duval S. (2005) The trim and fill method. Publication bias in meta\u2010analysis: Prevention, assessment and adjustments. pp 127\u201344. https:\/\/doi.org\/10.1002\/0470870168.ch8","DOI":"10.1002\/0470870168.ch8"},{"key":"10716_CR37","unstructured":"Mahboobi S, Iraj B, Maghsoudi Z, Feizi A, Ghiasvand R, Askari G et al (2014) The effects of probiotic supplementation on markers of blood lipids, and blood pressure in patients with prediabetes: a randomized clinical trial. Int J Prev Med 5(10):1239\u20131246"},{"key":"10716_CR38","doi-asserted-by":"crossref","unstructured":"Asemi Z, Bahmani S, Shakeri H, Jamal A, Faraji A-M (2015) Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes. Int J Diabetes Dev Ctries\u00a035:90\u20135","DOI":"10.1007\/s13410-013-0187-2"},{"key":"10716_CR39","doi-asserted-by":"crossref","unstructured":"Firouzi S, Majid HA, Ismail A, Kamaruddin NA, Barakatun-Nisak M-Y (2017) Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. Eur J Nutr 56:1535\u20131550","DOI":"10.1007\/s00394-016-1199-8"},{"key":"10716_CR40","doi-asserted-by":"crossref","unstructured":"Mobini R, Tremaroli V, St\u00e5hlman M, Karlsson F, Levin M, Ljungberg M et al (2017) Metabolic effects of L actobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 19(4):579\u2013589","DOI":"10.1111\/dom.12861"},{"key":"10716_CR41","doi-asserted-by":"crossref","unstructured":"Sabico S, Al-Mashharawi A, Al-Daghri NM, Yakout S, Alnaami AM, Alokail MS et al (2017) Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication na\u00efve T2DM patients: a randomized clinical trial. J Transl Med 15:1\u20139","DOI":"10.1186\/s12967-017-1354-x"},{"key":"10716_CR42","doi-asserted-by":"crossref","unstructured":"Hsieh M-C, Tsai W-H, Jheng Y-P, Su S-L, Wang S-Y, Lin C-C et al (2018) The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Sci Rep 8(1):16791","DOI":"10.1038\/s41598-018-35014-1"},{"key":"10716_CR43","doi-asserted-by":"crossref","unstructured":"Raygan F, Rezavandi Z, Bahmani F, Ostadmohammadi V, Mansournia MA, Tajabadi-Ebrahimi M et al (2018) The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease. Diabetol Metab Syndr 10:1\u20137","DOI":"10.1186\/s13098-018-0353-2"},{"key":"10716_CR44","doi-asserted-by":"crossref","unstructured":"Farrokhian A, Raygan F, Soltani A, Tajabadi-Ebrahimi M, Sharifi Esfahani M, Karami AA et al (2019) The effects of synbiotic supplementation on carotid intima-media thickness, biomarkers of inflammation, and oxidative stress in people with overweight, diabetes, and coronary heart disease: a randomized, double-blind, placebo-controlled trial. Probiotics Antimicrob Proteins 11:133\u2013142","DOI":"10.1007\/s12602-017-9343-1"},{"key":"10716_CR45","doi-asserted-by":"crossref","unstructured":"Khalili L, Alipour B, Jafar-Abadi MA, Faraji I, Hassanalilou T, Abbasi MM et al (2019) The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Iran Biomed J 23(1):68","DOI":"10.29252\/ibj.23.1.68"},{"key":"10716_CR46","doi-asserted-by":"crossref","unstructured":"Sabico S, Al-Mashharawi A, Al-Daghri NM, Wani K, Amer OE, Hussain DS et al (2019) Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: a randomized, doubleblind, placebo-controlled trial. Clin Nutr 38(4):1561\u20131569","DOI":"10.1016\/j.clnu.2018.08.009"},{"key":"10716_CR47","doi-asserted-by":"crossref","unstructured":"Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X et al (2020) Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun 11(1):5015","DOI":"10.1038\/s41467-020-18414-8"},{"key":"10716_CR48","doi-asserted-by":"crossref","unstructured":"Ahmadian F, Razmpoosh E, Ejtahed H-S, Javadi M, Mirmiran P, Azizi F (2022) Effects of probiotic supplementation on major cardiovascular-related parameters in patients with type-2 diabetes mellitus: a secondary-data analysis of a randomized doubleblind controlled trial. Diabetol Metab Syndr 14(1):52","DOI":"10.1186\/s13098-022-00822-z"},{"key":"10716_CR49","doi-asserted-by":"crossref","unstructured":"Barthow C, Hood F, Crane J, Huthwaite M, Weatherall M, Parry-Strong A et al (2022) A randomised controlled trial of a probiotic and a prebiotic examining metabolic and mental health outcomes in adults with pre-diabetes. BMJ Open 12(3):e055214","DOI":"10.1136\/bmjopen-2021-055214"},{"key":"10716_CR50","doi-asserted-by":"publisher","unstructured":"AkbariRad M, Shariatmaghani SS, Razavi BM, Majd HM, Shakhsemampour Z, Sarabi M et al (2023) Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study. Diabetol Metab Syndr 15(1):71. https:\/\/doi.org\/10.1186\/s13098-023-01050-9","DOI":"10.1186\/s13098-023-01050-9"},{"key":"10716_CR51","doi-asserted-by":"crossref","unstructured":"Hasanpour A, Babajafari S, Mazloomi SM, Shams M (2023) The effects of soymilk plus probiotics supplementation on cardiovascular risk factors in patients with type 2 diabetes mellitus: a randomized clinical trial. BMC Endocr Disord 23(1):36","DOI":"10.1186\/s12902-023-01290-w"},{"key":"10716_CR52","doi-asserted-by":"crossref","unstructured":"Velayati A, Kareem I, Sedaghat M, Sohrab G, Nikpayam O, Hedayati M et al (2023) Does symbiotic supplementation which contains Bacillus coagulans, Lactobacillus rhamnosus, Lactobacillus acidophilus and fructooligosaccharide has favourite effects in patients with type-2 diabetes? A randomised, double-blind, placebo-controlled trial. Arch Physiol Biochem 129(6):1211\u20131218","DOI":"10.1080\/13813455.2021.1928225"},{"key":"10716_CR53","doi-asserted-by":"crossref","unstructured":"Zikou E, Dovrolis N, Dimosthenopoulos C, Gazouli M, Makrilakis K (2023) The effect of probiotic supplements on metabolic parameters of people with type 2 diabetes in Greece\u2014a randomized, double-blind, placebo-controlled study. Nutrients 15(21):4663","DOI":"10.3390\/nu15214663"},{"key":"10716_CR54","doi-asserted-by":"crossref","unstructured":"Hendijani F, Akbari V (2018) Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: a systematic review and meta-analysis. Clin Nutr 37(2):532\u2013541","DOI":"10.1016\/j.clnu.2017.02.015"},{"key":"10716_CR55","doi-asserted-by":"crossref","unstructured":"Naseri K, Saadati S, Yari Z, Asbaghi O, Hezaveh ZS, Mafi D et al (2022) Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: a gradeassessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol Res 182:106288","DOI":"10.1016\/j.phrs.2022.106288"},{"key":"10716_CR56","doi-asserted-by":"crossref","unstructured":"Tian Y, Xia J, Li L, Yang L, Xiao H, Gao G et al (2025) Effects of probiotics, prebiotics and synbiotics supplementation on cardiovascular risk factors in patients with type 2 diabetes mellitus: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Food Sci Hum Wellness 14(1):9250002","DOI":"10.26599\/FSHW.2024.9250002"},{"key":"10716_CR57","doi-asserted-by":"publisher","unstructured":"Chen T, Wang J, Liu Z (2024) Effect of supplementation with probiotics or synbiotics on cardiovascular risk factors in patients with metabolic syndrome: a systematic review and meta-analysis of randomized clinical trials. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1282699","DOI":"10.3389\/fendo.2023.1282699"},{"key":"10716_CR58","doi-asserted-by":"crossref","unstructured":"Balthazar CF, de Moura NA, Romualdo GR, Rocha RS, Pimentel TC, Esmerino EA et al (2021) Synbiotic sheep milk ice cream reduces chemically induced mouse colon carcinogenesis. J Dairy Sci 104(7):7406\u20137414","DOI":"10.3168\/jds.2020-19979"},{"issue":"1","key":"10716_CR59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/1471-0307.12918","volume":"76","author":"S Song","year":"2023","unstructured":"Song S, Jeong A, Lim J, Kim BK, Park DJ, Oh S (2023) Lactiplantibacillus plantarum L67 probiotics vs paraprobiotics for reducing pro-inflammatory responses in colitis mice. Int J Dairy Technol 76(1):168\u2013177","journal-title":"Int J Dairy Technol"},{"key":"10716_CR60","doi-asserted-by":"crossref","unstructured":"Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K et al (2018) Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci 132(6):701\u2013718","DOI":"10.1042\/CS20180087"},{"key":"10716_CR61","doi-asserted-by":"crossref","unstructured":"Guyenet PG, Stornetta RL, Souza GMPR, Abbott SBG, Brooks VL (2020) Neuronal networks in hypertension. Hypertension 76(2):300\u2013311","DOI":"10.1161\/HYPERTENSIONAHA.120.14521"},{"key":"10716_CR62","doi-asserted-by":"crossref","unstructured":"Li J, Yang X, Zhou X, Cai J (2020) The role and mechanism of intestinal flora in blood pressure regulation and hypertension development. Antioxid Redox Signal 34(10):811\u2013830","DOI":"10.1089\/ars.2020.8104"},{"key":"10716_CR63","doi-asserted-by":"crossref","unstructured":"Liu J, An N, Ma C, Li X, Zhang J, Zhu W et al (2018) Correlation analysis of intestinal flora with hypertension. Exp Ther Med 16(3):2325\u20132330","DOI":"10.3892\/etm.2018.6500"},{"key":"10716_CR64","doi-asserted-by":"crossref","unstructured":"Livshits G, Kalinkovich A (2019) Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis. Ageing Res Rev 56:100980","DOI":"10.1016\/j.arr.2019.100980"},{"key":"10716_CR65","doi-asserted-by":"crossref","unstructured":"Muralitharan RR, Jama HA, Xie L, Peh A, Snelson M, Marques FZ (2020) Microbial peer pressure. Hypertension 76(6):1674\u20131687","DOI":"10.1161\/HYPERTENSIONAHA.120.14473"},{"key":"10716_CR66","doi-asserted-by":"publisher","unstructured":"Chen Z, Liang W, Liang J, Dou J, Guo F, Zhang D et al (2023) Probiotics: functional food ingredients with the potential to reduce hypertension. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2023.1220877","DOI":"10.3389\/fcimb.2023.1220877"},{"key":"10716_CR67","doi-asserted-by":"crossref","unstructured":"Yang Z, Wang Q, Liu Y, Wang L, Ge Z, Li Z et al (2023) Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens 45(1):2195135","DOI":"10.1080\/10641963.2023.2195135"},{"issue":"3","key":"10716_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41581-022-00654-0","volume":"19","author":"JA O\u2019Donnell","year":"2023","unstructured":"O\u2019Donnell JA, Zheng T, Meric G, Marques FZ (2023) The gut microbiome and hypertension. Nat Rev Nephrol 19(3):153\u2013167","journal-title":"Nat Rev Nephrol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10716-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:58:15Z","timestamp":1774342695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10716"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10716-x","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"5 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}